Skip to main content

Table 2 Medical profiles and heights of the CAH participants

From: Health-related quality of life of female patients with congenital adrenal hyperplasia in Malaysia

Variables CAH participants
Age group I
10–12 years
(n = 12)
Age group II
13–17 years
(n = 29)
Age group III
≥ 18 years
(n = 18)
Total
N = 59
f % f % f % f %
CAH variants
 SW-CAH 7 58.3 18 62.1 15 83.3 40 67.8
 SV-CAH 5 41.7 11 37.9 2 11.1 18 30.5
 NC-CAH 0 0 1 5.6 1 1.7
Daily corticosteroid replacement
 Prednisolone 4 33.3 17 58.6 13 72.2 34 57.6
 Hydrocortisone 8 66.7 12 41.4 5 27.8 25 42.2
On mineralocorticoids 10 83.3 23 79.3 17 94.4 50 84.7
Hypertensive 0 0 3 10.3 3 16.7 6 10.2
Participants’ perceived compliance to medications
 Excellent 3 25.0 11 37.9 6 33.3 30 33.9
 Intermediate 8 66.7 13 44.8 8 44.4 29 49.2
 Poor 1 8.3 5 17.2 4 22.2 10 16.9
Other co-morbidities 1 8.3 9 31.0 7 38.9 17 28.8
Had precocious puberty 6 50.0 12 41.4 3 16.7 21 35.6
Learning disability 2 16.7 6 20.7 2 11.1 10 16.9
Affected sibling (s) 5 41.7 15 51.7 8 44.4 28 47.5
Height (cm), Mean (SD) 142.7 (9.0) 151.0 (6.8) 149.0 (5.6)   
Obese or overweight 5 41.6 10 34.4 6 33.4 21 35.6